tolerogenic dendritic cells
/ Precigen, Benitec BioPharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 20, 2020
An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes
(clinicaltrials.gov)
- P1; N=7; Recruiting; Sponsor: City of Hope Medical Center; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Diabetes • Hypoglycemia • Metabolic Disorders • Type 1 Diabetes Mellitus
October 19, 2020
An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes
(clinicaltrials.gov)
- P1; N=7; Not yet recruiting; Sponsor: City of Hope Medical Center
Clinical • New P1 trial • Diabetes • Hypoglycemia • Metabolic Disorders • Type 1 Diabetes Mellitus
1 to 2
Of
2
Go to page
1